Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

readOnlyHint=true already tells the agent this is a safe read, so extra behavioral disclosure is not strictly required. The description adds the enumerated result fields, which is useful because no output schema exists, but it says nothing about result caps, truncation, or pagination behavior (the schema's ~26k ceiling only shows up in the parameter docs).

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

Two tight clauses with the purpose front-loaded; the field enumeration is dense but informative. The trailing 'openFDA device/recall endpoint' sentence is mildly redundant with the tool name, keeping it from a full 5.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, listing the returned fields is exactly the right compensation, and the schema fully covers query syntax and pagination. What is missing is any note on result limits/responses when the query matches nothing or exceeds the documented ceiling, but overall it is sufficient to call the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100% and all four parameters (skip, sort, limit, search) are documented thoroughly in the schema, including Lucene syntax, ranges, and pagination limits. The description contributes no additional parameter semantics, so the baseline 3 applies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb and resource ('Search medical device recalls') and enumerates the returned data (reason, recalling firm, classification, product code, status), which scopes it apart from search_drug_recalls, search_food_recalls, and search_device_events. It stops short of explicitly naming those siblings as alternatives, so the differentiation remains implicit via the dataset name.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is no when-to-use guidance, no exclusions, and no routing to alternatives such as count for totals or openfda_query for cross-dataset queries. The only usage hint is the provenance note 'openFDA device/recall endpoint', which identifies the source but not the conditions under which an agent should pick this tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.